Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15940671rdf:typepubmed:Citationlld:pubmed
pubmed-article:15940671lifeskim:mentionsumls-concept:C0004651lld:lifeskim
pubmed-article:15940671lifeskim:mentionsumls-concept:C0017349lld:lifeskim
pubmed-article:15940671lifeskim:mentionsumls-concept:C1185625lld:lifeskim
pubmed-article:15940671lifeskim:mentionsumls-concept:C0014239lld:lifeskim
pubmed-article:15940671lifeskim:mentionsumls-concept:C0003320lld:lifeskim
pubmed-article:15940671lifeskim:mentionsumls-concept:C1257986lld:lifeskim
pubmed-article:15940671lifeskim:mentionsumls-concept:C0597177lld:lifeskim
pubmed-article:15940671pubmed:issue7lld:pubmed
pubmed-article:15940671pubmed:dateCreated2005-7-6lld:pubmed
pubmed-article:15940671pubmed:abstractTextIt has been shown that exogenous antigens can access the MHC class I pathway of professional antigen-processing cells. However, details as to how the MHC class I-peptide complex forms in the presentation pathway are still poorly understood. Here we used MHC class I-peptide-specific antibodies to investigate the formation and intracellular location of class I-peptide complexes in macrophages. We observed that the formation of class I-peptide complexes occurs within a few hours and lasts for another few hours on the cell surface of macrophages following loading with filamentous phage particles. The class I-peptide complexes in the process were co-localized with MHC class II molecules and endocytic system markers. Moreover, endosomal compartments containing class I-peptide complexes were found within intracellular organelles stained by DiOC6 and calnexin. In addition, the cross-presentation of phage particles was transporter associated with antigen processing (TAP)-dependent and sensitive to proteasome inhibitors and NH(4)Cl. These data suggest that endocytosed phage particles may be processed and cross-presented in organelles positive for phagosome and endoplasmic reticulum (ER) markers via a classical ER MHC class I loading mechanism.lld:pubmed
pubmed-article:15940671pubmed:languageenglld:pubmed
pubmed-article:15940671pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15940671pubmed:citationSubsetIMlld:pubmed
pubmed-article:15940671pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15940671pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15940671pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15940671pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15940671pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15940671pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15940671pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15940671pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15940671pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15940671pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15940671pubmed:statusMEDLINElld:pubmed
pubmed-article:15940671pubmed:monthJullld:pubmed
pubmed-article:15940671pubmed:issn0014-2980lld:pubmed
pubmed-article:15940671pubmed:authorpubmed-author:WuYuzhangYlld:pubmed
pubmed-article:15940671pubmed:authorpubmed-author:ZhaoJianpingJlld:pubmed
pubmed-article:15940671pubmed:authorpubmed-author:BianJiangJlld:pubmed
pubmed-article:15940671pubmed:authorpubmed-author:ZhouWeiWlld:pubmed
pubmed-article:15940671pubmed:authorpubmed-author:WanYingYlld:pubmed
pubmed-article:15940671pubmed:authorpubmed-author:JiaZhengcaiZlld:pubmed
pubmed-article:15940671pubmed:authorpubmed-author:EngbergJanJlld:pubmed
pubmed-article:15940671pubmed:authorpubmed-author:ZouLiyunLlld:pubmed
pubmed-article:15940671pubmed:authorpubmed-author:ZhouJingranJlld:pubmed
pubmed-article:15940671pubmed:authorpubmed-author:LiangYunfeiYlld:pubmed
pubmed-article:15940671pubmed:issnTypePrintlld:pubmed
pubmed-article:15940671pubmed:volume35lld:pubmed
pubmed-article:15940671pubmed:ownerNLMlld:pubmed
pubmed-article:15940671pubmed:authorsCompleteYlld:pubmed
pubmed-article:15940671pubmed:pagination2041-50lld:pubmed
pubmed-article:15940671pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:15940671pubmed:meshHeadingpubmed-meshheading:15940671...lld:pubmed
pubmed-article:15940671pubmed:meshHeadingpubmed-meshheading:15940671...lld:pubmed
pubmed-article:15940671pubmed:meshHeadingpubmed-meshheading:15940671...lld:pubmed
pubmed-article:15940671pubmed:meshHeadingpubmed-meshheading:15940671...lld:pubmed
pubmed-article:15940671pubmed:meshHeadingpubmed-meshheading:15940671...lld:pubmed
pubmed-article:15940671pubmed:meshHeadingpubmed-meshheading:15940671...lld:pubmed
pubmed-article:15940671pubmed:meshHeadingpubmed-meshheading:15940671...lld:pubmed
pubmed-article:15940671pubmed:meshHeadingpubmed-meshheading:15940671...lld:pubmed
pubmed-article:15940671pubmed:meshHeadingpubmed-meshheading:15940671...lld:pubmed
pubmed-article:15940671pubmed:meshHeadingpubmed-meshheading:15940671...lld:pubmed
pubmed-article:15940671pubmed:meshHeadingpubmed-meshheading:15940671...lld:pubmed
pubmed-article:15940671pubmed:meshHeadingpubmed-meshheading:15940671...lld:pubmed
pubmed-article:15940671pubmed:meshHeadingpubmed-meshheading:15940671...lld:pubmed
pubmed-article:15940671pubmed:meshHeadingpubmed-meshheading:15940671...lld:pubmed
pubmed-article:15940671pubmed:meshHeadingpubmed-meshheading:15940671...lld:pubmed
pubmed-article:15940671pubmed:meshHeadingpubmed-meshheading:15940671...lld:pubmed
pubmed-article:15940671pubmed:meshHeadingpubmed-meshheading:15940671...lld:pubmed
pubmed-article:15940671pubmed:meshHeadingpubmed-meshheading:15940671...lld:pubmed
pubmed-article:15940671pubmed:meshHeadingpubmed-meshheading:15940671...lld:pubmed
pubmed-article:15940671pubmed:meshHeadingpubmed-meshheading:15940671...lld:pubmed
pubmed-article:15940671pubmed:meshHeadingpubmed-meshheading:15940671...lld:pubmed
pubmed-article:15940671pubmed:meshHeadingpubmed-meshheading:15940671...lld:pubmed
pubmed-article:15940671pubmed:year2005lld:pubmed
pubmed-article:15940671pubmed:articleTitleCross-presentation of phage particle antigen in MHC class II and endoplasmic reticulum marker-positive compartments.lld:pubmed
pubmed-article:15940671pubmed:affiliationThe Institute of Immunology, PLA, The Third Military Medical University, Shapingba District, Chongqing, PR China.lld:pubmed
pubmed-article:15940671pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15940671pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed